Filing Details

Accession Number:
0001127602-22-014263
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-12 16:22:00
Reporting Period:
2022-05-10
Accepted Time:
2022-05-12 16:22:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365343 Francois Nader C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-10 23,100 $18.87 23,803 No 4 M Direct
Common Stock Disposition 2022-05-10 3,196 $136.10 20,607 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-05-10 23,100 $0.00 23,100 $18.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,620 2029-12-10 No 4 M Direct
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 9, 2022.
  2. Represents the number of shares sold by the Reporting Person to cover the payment of the exercise price of the option.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.10 to $136.17. Full information regarding the number of shares sold at each separate price can befurnished to the SEC staff upon request.
  4. This option is fully vested and exercisable.